Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

ELMD

Strong BuyFallen FavouriteFLAG

Electromed, Inc. · Healthcare · United States · $248M · Avg Vol: $3M/d

88
StockRank
Get insider-trade alerts
Q
91
V
47
M
49
P/E (TTM)
21.5x
ROE
23.3%
D/E
0.0x
Dividend %
AI CONVICTION THESIS

Electromed has the highest quality reading in this batch at Q91, but value at V26 is far below the floor and insiders sold 0.74% of shares outstanding. Excellent business, fully priced, with management taking money off the table.

COMPANY DESCRIPTION

Electromed, Inc. designs, manufactures, and markets airway clearance technologies, primarily its proprietary SmartVest Airway Clearance System, for patients with chronic lung diseases like bronchiectasis. The company operates as a niche market leader in the High Frequency Chest Wall Oscillation (HFCWO) space. Its competitive moat is built on a direct-to-patient distribution model, strong clinical evidence supporting its products, and high reimbursement success rates with insurance providers.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGRTTM2027E2028EFwd CAGR
Revenue41.7M48.1M54.7M64.0M15.4%73.8M72.1M79.9M7.7%
EPS0.270.370.600.8948.8%1.301.001.169.1%
Shares8.5M8.6M8.6M8.3M-1.5%8.4M
Debt
Equity34.2M37.7M44.5M43.2M8.1%
Op CF-0.7M1.3M9.1M11.4M194.3%9.7M
Inv CF-1.5M-1.7M-0.4M-0.3M
Fin CF-1.5M-0.4M36.0K-11.9M
Loading 1Y...
PRICE (1Y)-32.6%
27.0730.9534.8338.7042.58Jul 29Aug 19Sep 9
SMA 50SMA 200

Close
$27.07
RSI (14)
12.8
52W High
$47.40
From 52W High
0.6%

SCORE BREAKDOWN

Quality
91
ROIC
22.3%92.2
ROE
23.3%91.1
GP/Assets
107.7%98.5
Op. Margin
19.7%82.5
FCF/Assets
15.5%93.9
Piotroski
790.5
Int. Cover
50.0x89.2
D/E Ratio
0.00x91.6
Current Ratio
4.69x70.1
Value
47
P/E (TTM)
21.5x56.8
EV/EBITDA
14.2x51.3
P/FCF
29.7x49.0
P/B
4.3x33.5
P/S
3.2x55.0
Div Yield
N/A
Momentum
49
52W High %
57%31.1
RS 6M
1%66.9
SMA 50/200
1.25x90.9
EPS Rev 4W
0.0%34.5
EPS Rev 12W
0.0%41.6
EPS Improve
-53%9.3
Q Growth
54%75.0

FUNDAMENTALS

Market Cap
$248M
P/E (Forward)
45.9x
Gross Margin
78.5%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ELMD are excluded.

TickerCompanyMkt CapStockRankSignal
ELMDElectromed, Inc.(you)$248M88Strong Buy
VMDViemed Healthcare, Inc.$336M87Strong Buy
TCMDTactile Systems Technology, Inc.$525M87Strong Buy
DCTHDelcath Systems, Inc.$567M87Strong Buy
AOTI.LAOTI, Inc.$194M61Hold
BVSBioventus Inc.$945M96Strong Buy
CNMDCONMED Corporation$1.5B87Strong Buy
VREXVarex Imaging Corporation$780M71Buy
INSPInspire Medical Systems, Inc.$1.8B83Strong Buy
RCELAVITA Medical, Inc.$320M48Hold

Peer medians: ROE -30.8% · P/E 27.1x · Gross margin 58.1%

Electromed, Inc. (ELMD): Stock Score Summary

Electromed, Inc. (ELMD) has a MoatMap StockRank of 88/100 based on Quality (91/100), Value (47/100), and Momentum (49/100) factor scores. The current signal is STRONG BUY. Electromed has the highest quality reading in this batch at Q91, but value at V26 is far below the floor and insiders sold 0.74% of shares outstanding. Excellent business, fully priced, with management taking money off the table.

Electromed, Inc. designs, manufactures, and markets airway clearance technologies, primarily its proprietary SmartVest Airway Clearance System, for patients with chronic lung diseases like bronchiectasis. The company operates as a niche market leader in the High Frequency Chest Wall Oscillation (HFCWO) space. Its competitive moat is built on a direct-to-patient distribution model, strong clinical evidence supporting its products, and high reimbursement success rates with insurance providers.

Key Financial Metrics

Price$27.07
Market Cap$248M
P/E (TTM)21.54
P/E (Forward)45.90
Price/Book4.34
Return on Equity23.3%
Return on Invested Capital22.3%
Debt/Equity0.00x
Gross Margin78.5%
Operating Margin19.7%
Revenue Growth11.6%
Free Cash Flow$8M

Electromed, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Electromed, Inc.’s (ELMD) StockRank?
MoatMap’s StockRank for Electromed, Inc. (ELMD) is 88/100, with a Strong Buy signal. It is a composite of Quality (91), Value (47), and Momentum (49) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does Electromed, Inc. have an economic moat?
Electromed, Inc. (ELMD) has a Quality factor score of 91/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Electromed, Inc. a buy, hold, or sell?
MoatMap’s current signal for Electromed, Inc. (ELMD) is Strong Buy, based on a StockRank of 88/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Electromed, Inc. in?
Electromed, Inc. (ELMD) operates in the Healthcare sector, specifically the Medical Devices industry (United States).